Alastair Whitington summarises highlights from the Commissioning Chemotherapy Services Conference
The Commissioning Chemotherapy Services Conference was held on 6 December, 2018 at the Pullman London St Pancras Hotel.1
Dr Jeanette Dickson, Vice-President, Clinical Oncology, Royal College of Radiologists, Consultant Clinical Oncologist, Mount Vernon Cancer Centre, and Chair of the United Kingdom Chemotherapy Chemotherapy Board, welcomed delegates to the meeting and outlined a wide-ranging programme covering an update on the cancer strategy and national initiatives through to the day-to-day challenges of accessing treatments for patients with cancer, adopting new technologies, and delivering a high-quality support system for patients with cancer.
UPDATE ON NATIONAL CANCER STRATEGY
David Fitzgerald, Director, NHS Cancer Programme, provided an overview of the NHS Cancer Programme and its long-term plan. While cancer waiting times continue to present a challenge, there was a small improvement (0.7%) in 1-year survival in 2015 compared with 2014. Future goals include increasing the proportion of patients diagnosed with cancer at an early stage from 50% to 75%, with the aim that 55,000 more people with cancer will achieve